Educational information, not medical advice — ask your doctor or midwife.
Track Jin Yin Hua (Honeysuckle) with reminders and record whether it helped, in the app.
Jin Yin Hua — literally 'gold and silver flower' in Chinese — refers to the flower buds of Lonicera japonica, harvested just before they open when their active compounds are most concentrated. It has been a cornerstone of Traditional Chinese Medicine for over a thousand years, prized for its ability to clear heat, detoxify, and fight infection. Today it is one of the most commercially produced medicinal herbs in China and is used widely across East Asian herbal medicine systems.
The herb works primarily through its rich content of chlorogenic acid and luteolin, which calm overactive immune responses, reduce inflammatory signaling, and inhibit the growth of bacteria and viruses. It is thought to help the body fight off pathogens while keeping the immune response from going into overdrive — a balance that makes it useful for both acute infections and chronic low-grade inflammation. It also has antioxidant activity that helps protect tissues from damage during illness.
Traditional tea (decoction) of the dried buds is the most historically used and culturally familiar form. Modern capsules and tablets standardized to chlorogenic acid content offer more precise dosing. Granules (instant powder tea) are popular in China for convenience. Tinctures provide a concentrated liquid option for flexible dosing. Topical preparations are used for skin infections, acne, and wound care.
Jin Yin Hua has appeared in major Chinese pharmacopeias since the Tang Dynasty (around 659 CE). It is prominently featured in the Bencao Gangmu (Compendium of Materia Medica, 1596) by Li Shizhen as a treatment for fever, sores, and toxic swellings. During more recent decades it became a key ingredient in widely used Chinese patent formulas such as Shuanghuanglian and Yinqiaosan, which are prescribed for respiratory infections across China. Its use has expanded globally as modern research has begun to validate its traditional applications.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
The published evidence for Jin Yin Hua (Honeysuckle) is weak or absent. That usually means no controlled trial has tested it, not that a trial found it ineffective — the two are different, and we grade only what has been published.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.